A Prospective, Multi-center, Single Armed Registry to Evaluate The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization

Trial Profile

A Prospective, Multi-center, Single Armed Registry to Evaluate The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Arsenic trioxide (Primary)
  • Indications Coronary artery restenosis; Coronary disorders; Ischaemic heart disorders; Myocardial ischaemia
  • Focus Adverse reactions
  • Acronyms PERFECT-I
  • Sponsors Beijing AmsinoMed Medical Device Co
  • Most Recent Events

    • 24 Jun 2017 Planned End Date changed from 1 Jun 2020 to 1 Apr 2021.
    • 19 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top